Insulin glargine Completed Phase 4 Trials for Coronary Artery Disease (CAD) Prevention

IndicationsStatusPurposePhase
CompletedPrevention4
clinicaltrials.gov IdentifierTitleDrugs
NCT02443402Sitagliptin in Non-Diabetic Patients Undergoing Cardiac Surgery